Workflow
MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Fraud Lawsuit with the Schall Law Firm
MetagenomiMetagenomi(US:MGX) GlobeNewswire News Roomยท2024-09-27 22:11

Core Viewpoint - A class action lawsuit has been filed against Metagenomi, Inc. for alleged violations of federal securities laws related to misleading statements made during its IPO [1][4]. Group 1: Lawsuit Details - The Schall Law Firm is representing investors who purchased Metagenomi's securities during its IPO on February 9, 2024, and encourages them to contact the firm before November 25, 2024 [2]. - The lawsuit claims that Metagenomi made false and misleading statements regarding its business relationship with Moderna, which was based on a Strategic Collaboration and License Agreement from October 29, 2021 [4]. Group 2: Impact on Investors - Following the announcement of the termination of the collaboration with Moderna, investors suffered damages as the truth about Metagenomi's misleading public statements was revealed [4].